Literature DB >> 21784103

Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration.

Aaron R Cooper1, Sanjeet Patel, Shantha Senadheera, Kathrin Plath, Donald B Kohn, Roger P Hollis.   

Abstract

Large-scale lentiviral vector (LV) concentration can be inefficient and time consuming, often involving multiple rounds of filtration and centrifugation. This report describes a simpler method using two tangential flow filtration (TFF) steps to concentrate liter-scale volumes of LV supernatant, achieving in excess of 2000-fold concentration in less than 3h with very high recovery (>97%). Large volumes of LV supernatant can be produced easily through the use of multi-layer flasks, each having 1720 cm(2) surface area and producing ∼560 mL of supernatant per flask. Combining the use of such flasks and TFF greatly simplifies large-scale production of LV. As a demonstration, the method is used to produce a very high titer LV (>10(10)TU/mL) and transduce primary human CD34+ hematopoietic stem/progenitor cells at high final vector concentrations with no overt toxicity. A complex LV (STEMCCA) for induced pluripotent stem cell (iPSC) generation is also concentrated from low initial titer and used to transduce and reprogram primary human fibroblasts with no overt toxicity. Additionally, a generalized and simple multiplexed real-time PCR assay is described for lentiviral vector titer and copy number determination.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784103      PMCID: PMC4276401          DOI: 10.1016/j.jviromet.2011.06.019

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  16 in total

1.  Generation of HIV-1 derived lentiviral vectors.

Authors:  Antonia Follenzi; Luigi Naldini
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  Ultraconserved elements in the human genome.

Authors:  Gill Bejerano; Michael Pheasant; Igor Makunin; Stuart Stephen; W James Kent; John S Mattick; David Haussler
Journal:  Science       Date:  2004-05-06       Impact factor: 47.728

3.  Upscaling of lentiviral vector production by tangential flow filtration.

Authors:  Martine Geraerts; Martine Michiels; Veerle Baekelandt; Zeger Debyser; Rik Gijsbers
Journal:  J Gene Med       Date:  2005-10       Impact factor: 4.565

4.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Authors:  R Zufferey; D Nagy; R J Mandel; L Naldini; D Trono
Journal:  Nat Biotechnol       Date:  1997-09       Impact factor: 54.908

5.  Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.

Authors:  Ute Modlich; Jens Bohne; Manfred Schmidt; Christof von Kalle; Sabine Knöss; Axel Schambach; Christopher Baum
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

6.  Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

Authors:  D L Haas; S S Case; G M Crooks; D B Kohn
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

7.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

8.  The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.

Authors:  Dennis L Haas; Carolyn Lutzko; Aaron C Logan; Gerald J Cho; Dianne Skelton; Xiao Jin Yu; Karen A Pepper; Donald B Kohn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

View more
  33 in total

1.  Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.

Authors:  Hardeep P Singh; Sijia Wang; Kevin Stachelek; Sunhye Lee; Mark W Reid; Matthew E Thornton; Cheryl Mae Craft; Brendan H Grubbs; David Cobrinik
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-13       Impact factor: 11.205

2.  Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.

Authors:  Caroline Y Kuo; Joseph D Long; Beatriz Campo-Fernandez; Satiro de Oliveira; Aaron R Cooper; Zulema Romero; Megan D Hoban; Alok V Joglekar; Georgia R Lill; Michael L Kaufman; Sorel Fitz-Gibbon; Xiaoyan Wang; Roger P Hollis; Donald B Kohn
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

3.  Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.

Authors:  Kismet Baldwin; Fabrizia Urbinati; Zulema Romero; Beatriz Campo-Fernandez; Michael L Kaufman; Aaron R Cooper; Katelyn Masiuk; Roger P Hollis; Donald B Kohn
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

4.  Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha.

Authors:  Patricia A Young; Reiko E Yamada; Kham R Trinh; Alex Vasuthasawat; Satiro De Oliveira; Douglas H Yamada; Sherie L Morrison; John M Timmerman
Journal:  J Interferon Cytokine Res       Date:  2018-06       Impact factor: 2.607

5.  Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeys.

Authors:  Denise Carbonaro Sarracino; Alice F Tarantal; C Chang I Lee; Michele Martinez; Xiangyang Jin; Xiaoyan Wang; Cinnamon L Hardee; Sabine Geiger; Christoph A Kahl; Donald B Kohn
Journal:  Mol Ther       Date:  2014-06-13       Impact factor: 11.454

6.  In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells.

Authors:  Emily Lowe; Laurel C Truscott; Satiro N De Oliveira
Journal:  Methods Mol Biol       Date:  2016

7.  Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locus.

Authors:  Alok V Joglekar; Roger P Hollis; Gabriela Kuftinec; Shantha Senadheera; Rebecca Chan; Donald B Kohn
Journal:  Mol Ther       Date:  2013-07-16       Impact factor: 11.454

8.  Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice.

Authors:  Carolina Gándara; Valerie Affleck; Elizabeth Ann Stoll
Journal:  Hum Gene Ther Methods       Date:  2018-01-24       Impact factor: 2.396

9.  Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.

Authors:  Francesca Giannoni; Cinnamon L Hardee; Jennifer Wherley; Eric Gschweng; Shantha Senadheera; Michael L Kaufman; Rebecca Chan; Ingrid Bahner; Vivian Gersuk; Xiaoyan Wang; David Gjertson; David Baltimore; Owen N Witte; James S Economou; Antoni Ribas; Donald B Kohn
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

10.  β-globin gene transfer to human bone marrow for sickle cell disease.

Authors:  Zulema Romero; Fabrizia Urbinati; Sabine Geiger; Aaron R Cooper; Jennifer Wherley; Michael L Kaufman; Roger P Hollis; Rafael Ruiz de Assin; Shantha Senadheera; Arineh Sahagian; Xiangyang Jin; Alyse Gellis; Xiaoyan Wang; David Gjertson; Satiro Deoliveira; Pamela Kempert; Sally Shupien; Hisham Abdel-Azim; Mark C Walters; Herbert J Meiselman; Rosalinda B Wenby; Theresa Gruber; Victor Marder; Thomas D Coates; Donald B Kohn
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.